title: A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers.
abstract: The complications associated with acquiring and storing whole blood for transfusions have launched substantial efforts to develop a blood substitute. The history of these efforts involves a complicated mixture of science, ethics, and business. This review focuses on clinical trials of the three hemoglobin-based oxygen carriers (HBOC) that have progressed to Phase II or III clinical trials: He-mAssist (Baxter; Deerfield, IL, US), PolyHeme (Northfield; Evanston, IL, US), and Hemopure (Biopure; Cambridge, MA, US). Published animal studies and clinical trials carried out in a perioperative setting have demonstrated that these products successfully transport and deliver oxygen, but all may induce hypertension and lead to unexpectedly low cardiac outputs. Overall, these studies suggest that HBOCs resulted in only modest blood saving during and after surgery, no improvement in mortality and an increased incidence of adverse reactions. To date, the results from these perioperative studies have not led to regulatory approval. All three companies instead chose to focus their efforts on large trials of trauma patients in the pre-hospital setting.Baxter abandoned the development of HemAssist after a trial in the U.S. was prematurely halted when the first 100 patients showed significantly increased mortality rates as compared to patients treated with blood products. Northfield's PolyHeme trial demonstrated a non-significant trend towards increased mortality and a very modest reduction in the subsequent need for blood. The testing of Biopure's Hemopure for trauma patients has been halted for several years because of FDA concerns over trial design and study justification. Ethical concerns have also been raised regarding the design and implementation of all HBOC clinical trials.Thus, the available evidence suggests that HemAssist, Polyheme, and Hemopure are associated with a significant level of cardiovascular dysfunction. The next generation of HBOCs remains under development.
authors.affiliation: Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA. jichen1@utmb.edu
authors.forename: Jiin-Yu
authors.initials: JY
authors.lastname: Chen
authors.forename: Michelle
authors.initials: M
authors.lastname: Scerbo
authors.forename: George
authors.initials: G
authors.lastname: Kramer
mesh_terms: D001802:Blood Substitutes / Q000009:adverse effects*; D002986:Clinical Trials as Topic / Q000941:ethics; D006454:Hemoglobins / Q000009:adverse effects / Q000145:classification*; D006801:Humans
chemical_list: D001802:Blood Substitutes; D006454:Hemoglobins; C509893:PolyHeme; C096798:HBOC 201
references.citation: J Trauma. 2008 Jun;64(6):1484-97
references.pmid: 18545113
references.citation: Science. 1933 Aug 4;78(2014):106-7
references.pmid: 17732672
references.citation: J Appl Physiol (1985). 1994 Nov;77(5):2348-54
references.pmid: 7868454
references.citation: Transfus Sci. 1995 Mar;16(1):5-17
references.pmid: 10155705
references.citation: Anesth Analg. 1996 Nov;83(5):921-7
references.pmid: 8895264
references.citation: Chron High Educ. 2006 Jun 16;52(41):A14-8
references.pmid: 16856301
references.citation: J Vasc Surg. 2000 Feb;31(2):299-308
references.pmid: 10664499
references.citation: Am J Bioeth. 2006 May-Jun;6(3):18-21
references.pmid: 16754441
references.citation: Stroke. 1999 May;30(5):993-6
references.pmid: 10229733
references.citation: JAMA. 2008 May 21;299(19):2304-12
references.pmid: 18443023
references.citation: Surg Infect (Larchmt). 2004 Winter;5(4):395-404
references.pmid: 15744131
references.citation: Clin Infect Dis. 2003 Jul 1;37(1):88-95
references.pmid: 12830413
references.citation: J Am Coll Surg. 1998 Aug;187(2):113-20; discussion 120-2
references.pmid: 9704955
references.citation: J Lab Clin Med. 1997 Sep;130(3):328-38
references.pmid: 9341993
references.citation: J Appl Physiol. 1949 Jan;1(7):469-89
references.pmid: 18104040
references.citation: Intensive Care Med. 2003 Mar;29(3):378-85
references.pmid: 12541156
references.citation: Anesth Analg. 2003 Aug;97(2):323-332
references.pmid: 12873912
references.citation: J Am Coll Surg. 2002 Oct;195(4):445-52; discussion 452-5
references.pmid: 12375748
references.citation: Am J Surg. 1998 Dec;176(6):612-7
references.pmid: 9926800
references.citation: Proc Natl Acad Sci U S A. 1976 Jun;73(6):2128-31
references.pmid: 1064880
references.citation: JAMA. 1999 Nov 17;282(19):1857-64
references.pmid: 10573278
references.citation: J Thorac Cardiovasc Surg. 2002 Jul;124(1):35-42
references.pmid: 12091806
references.citation: Shock. 2005 Apr;23(4):337-43
references.pmid: 15803057
references.citation: Mil Med. 2004 Jul;169(7):546-50
references.pmid: 15291188
references.citation: Arch Surg. 1997 Jun;132(6):620-4; discussion 624-5
references.pmid: 9197854
references.citation: Anesth Analg. 2002 Apr;94(4):799-808, table of contents
references.pmid: 11916776
references.citation: Trans Assoc Am Physicians. 1968;81:147-52
references.pmid: 5721397
references.citation: Anesthesiology. 2000 Mar;92(3):646-56
references.pmid: 10719942